4.7 Article

Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-hip ratio and body mass index in type 2 diabetes

Jiang-Feng Ke et al.

Summary: Comparing the associations between four anthropometric indices and cardio-cerebrovascular events in Chinese T2DM patients, it was found that waist-to-height ratio (WHtR) had a stronger association and may be a better indicator for evaluating cardiovascular risks in this population.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Article Endocrinology & Metabolism

Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study

Zhi-Hui Zhang et al.

Summary: This study found that increased serum RBP levels were independently associated with the presence of NAFLD in Chinese T2DM inpatients. This suggests that serum RBP levels may be used as one of the indicators to assess the risk of NAFLD in T2DM patients.

DIABETES & METABOLISM JOURNAL (2022)

Review Biochemistry & Molecular Biology

Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications

Brent R. Stockwell

Summary: This review describes the key regulators of ferroptosis and provides an overview of metabolism, ROS biology, and iron biology. Additionally, it highlights the important concepts and unanswered questions in the field of ferroptosis. The future holds promise for further breakthroughs in understanding the mechanisms of ferroptosis and utilizing it for therapeutic purposes.
Review Gastroenterology & Hepatology

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease

Huapeng Lin et al.

Summary: MAFLD is the most common chronic liver disease affecting a significant portion of the global adult population, with the potential to lead to complications such as cirrhosis and cancer. While cardiovascular disease remains the leading cause of death in patients, the proportion of deaths from hepatic complications increases as the disease progresses. Additionally, patients with MAFLD are at increased risk of extrahepatic cancers, though a definitive causal relationship has yet to be established.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2021)

Article Endocrinology & Metabolism

Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy

Bingwei Ma et al.

Summary: The study revealed that iron is associated with hepatic steatosis in obese patients, with significantly higher iron levels in patients with severe NAFLD. LSG surgery may decrease iron levels and improve fat deposition in the liver.

OBESITY FACTS (2021)

Article Cardiac & Cardiovascular Systems

Insulin Therapy Is Associated With an Increased Risk of Carotid Plaque in Type 2 Diabetes: A Real-World Study

Jiang-Feng Ke et al.

Summary: The study found that in patients with type 2 diabetes, those receiving insulin therapy have a significantly increased risk of carotid plaque, with both men and women showing a higher risk compared to those not receiving insulin therapy. Additionally, patients on insulin therapy exhibited more severe insulin resistance.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Medicine, General & Internal

Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study

Ya-Ping Huang et al.

Summary: The prevalence of MAFLD among government employees in Tianjin is significantly higher than the national average in China, with higher rates in men than in women. The risk of MAFLD increases with age and BMI, especially for BMI >= 31.9 kg/m(2).

BMJ OPEN (2021)

Article Gastroenterology & Hepatology

Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study

Yu-ling Chen et al.

Summary: MAFLD is prevalent in China and varies considerably among different age, sex, BMI, and female menopausal status groups. MAFLD is related to metabolic disorders, especially obesity, while metabolic disorders also play important roles in the occurrence of MAFLD in nonobese individuals. MAFLD patients exhibit a high prevalence of metabolic syndrome, dyslipidaemia, hyperuricaemia, and elevated liver enzymes. MAFLD tends to coexist with systemic metabolic disorders, and a deep inner relationship may exist between MAFLD and metabolic syndrome. Metabolic disorders should be considered to improve the management of MAFLD.

BMC GASTROENTEROLOGY (2021)

Article Endocrinology & Metabolism

Serum ferritin is correlated with non-alcoholic fatty liver disease in middle-aged and older patients with type 2 diabetes

Jun-Xin Yan et al.

Summary: This study found a significant correlation between serum ferritin levels and NAFLD in patients with T2DM, with serum ferritin identified as an independent risk factor for NAFLD in T2DM patients.

ENDOCRINE CONNECTIONS (2021)

Review Gastroenterology & Hepatology

Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)

Patrizia Burra et al.

Summary: NAFLD/NASH is a sex-dimorphic disease, with a higher prevalence in men. Factors such as sexual category, sex hormones, and gender habits interact with numerous NAFLD factors, altering risk profiles and phenotypes. A better understanding of sex differences in NAFLD could lead to personalized therapies.

LIVER INTERNATIONAL (2021)

Article Multidisciplinary Sciences

Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults

Huan-Huan Yang et al.

Summary: This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018 to investigate the relationship between serum iron levels and nonalcoholic fatty liver disease (NAFLD) and advanced hepatic fibrosis (AHF). The results showed that higher serum iron levels were associated with a lower risk of NAFLD in both males and females, and a lower risk of AHF in females, but not in males. There were no significant racial/ethnical differences in these associations.

SCIENTIFIC REPORTS (2021)

Article Endocrinology & Metabolism

Genetic Support of A Causal Relationship Between Iron Status and Type 2 Diabetes: A Mendelian Randomization Study

Xinhui Wang et al.

Summary: Using Mendelian Randomization analysis, a causal link was found between increased systemic iron status and an increased risk of type 2 diabetes. Further research and careful interpretation of these findings are crucial for reducing the risk of type 2 diabetes.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Endocrinology & Metabolism

Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus

Daniel Ferguson et al.

Summary: NAFLD is the most prevalent liver disease worldwide, with no approved pharmacological therapies available. The spectrum of severity ranges from steatosis to NASH, which is linked to increased risks of liver cancer and cirrhosis. Therefore, a holistic approach and ongoing therapeutic options are necessary to address the global health burden of these diseases.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Article Cell Biology

The Relationship between Serum Trace Elements and Oxidative Stress of Patients with Different Types of Cancer

Yu-wei Yang et al.

Summary: Oxidative stress and serum trace element levels are correlated with cancer occurrence and development, with different types of cancer patients showing varying levels of OxS parameters and trace elements. Changes in copper concentrations are closely associated with OxS parameters and the risk of multiple tumors.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Endocrinology & Metabolism

Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload

Sandro Altamura et al.

Summary: The study reveals that hepatic iron accumulation may exacerbate symptoms related to metabolic syndrome and type 2 diabetes. It suggests that iron depletion strategies in combination with anti-diabetic drugs could potentially improve insulin resistance and diabetic late complications.

MOLECULAR METABOLISM (2021)

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Endocrinology & Metabolism

Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity

Katharina Moerwald et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Review Gastroenterology & Hepatology

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

Zobair M. Younossi et al.

JOURNAL OF HEPATOLOGY (2019)

Article Endocrinology & Metabolism

Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients

Reham E. Amin et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)

Article Genetics & Heredity

Uncoupled iron homeostasis in type 2 diabetes mellitus

Sandro Altamura et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2017)

Article Endocrinology & Metabolism

Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes

Cui-Chun Zhao et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)

Review Gastroenterology & Hepatology

Iron and non-alcoholic fatty liver disease

Laurence J. Britton et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia

Luca Valenti et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Pharmacology & Pharmacy

Early onset type 2 diabetes: risk factors, clinical impact and management

Emma Wilmot et al.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2014)

Review Cell Biology

Iron and Diabetes Risk

Judith A. Simcox et al.

CELL METABOLISM (2013)

Review Medicine, General & Internal

Iron homeostasis in the Metabolic Syndrome

Christian Datz et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Gastroenterology & Hepatology

Characteristics and diagnosis of NAFLD/NASH

Etsuko Hashimoto et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Review Biochemistry & Molecular Biology

Non-transferrin bound iron: A key role in iron overload and iron toxicity

Pierre Brissot et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)

Article Gastroenterology & Hepatology

Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis

Umbreen Ahmed et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

Review Gastroenterology & Hepatology

Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target

Paola Dongiovanni et al.

JOURNAL OF HEPATOLOGY (2011)

Article Nutrition & Dietetics

Body fat distribution and insulin resistance: Beyond obesity in nonalcoholic fatty liver disease among overweight men

Seung Ha Park et al.

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2007)

Article Gastroenterology & Hepatology

NAFLD and hyperinsulinemia are major determinants of serum ferritin levels

Shira Zelber-Sagi et al.

JOURNAL OF HEPATOLOGY (2007)

Article Endocrinology & Metabolism

Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status

Ann Van Campenhout et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)

Letter Gastroenterology & Hepatology

Serum iron levels and hepatic iron overload in patients with nonalcoholic steatohepatitis

Ajay Duseja et al.

DIGESTIVE DISEASES AND SCIENCES (2006)

Letter Gastroenterology & Hepatology

Insulin resistance influences iron metabolism and hepatic steatosis in type II diabetes

M Viganò et al.

GASTROENTEROLOGY (2000)